When sponsors or manufacturers change their existing methods to the implemented Q4B-evaluated pharmacopoeia texts that are referenced in Section 2.1 of this annex , any change notification , variation .And/or prior approval procedures should be handled in accordance with established regiona regulatory mechanisms pertaining to compendial changes .Details of implementation requirements will be provided in the notification by MHLW when this annex is implemented .
……